Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea
· Delayed Price · Currency is KRW 3,895.00
-25.00 (-0.64%)
At close: Apr 28, 2026
KOSDAQ:142280 Revenue
In the year 2025, Green Cross Medical Science had annual revenue of 108.41B KRW with 4.39% growth. Green Cross Medical Science had revenue of 25.05B in the quarter ending December 31, 2025, a decrease of -9.74%.
Revenue
108.41B
Revenue Growth
+4.39%
P/S Ratio
0.78
Revenue / Employee
888.63M
Employees
122
Market Cap
84.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 108.41B | 4.56B | 4.39% |
| Dec 31, 2024 | 103.85B | 9.84B | 10.47% |
| Dec 31, 2023 | 94.01B | -19.10B | -16.88% |
| Dec 31, 2022 | 113.11B | 11.43B | 11.25% |
| Dec 31, 2021 | 101.67B | -11.70B | -10.32% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB Panagene | 15.05B |
| Protia | 15.12B |
| Cytogen | 26.05B |
| Seoulin Bioscience | 77.09B |
| GeneMatrix | 4.72B |
| GENINUS | 10.48B |
| PeopleBio | 2.85B |
| 3billion | 11.71B |